| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/17/2008 | CN100418981C Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 09/17/2008 | CN100418574C chromatin peptide for blocking human HIF-1 alpha gene and regulating network downstream related gene |
| 09/16/2008 | US7425669 Useful in reducing the damage caused by plant pathogens such as fungi and bacteria |
| 09/16/2008 | US7425667 Methods to produce desired proteins in plants |
| 09/16/2008 | US7425666 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants |
| 09/16/2008 | US7425665 Protein kinase stress-related proteins and methods of use in plants |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425621 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders |
| 09/16/2008 | US7425617 Antibodies to the cell cycle regulatory protein p16 |
| 09/16/2008 | US7425616 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 09/16/2008 | US7425615 Protein for use in the treatment of lysosomal storage defects |
| 09/16/2008 | US7425614 Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor |
| 09/16/2008 | US7425613 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic |
| 09/16/2008 | US7425612 Ring finger protein 43 for use as diagnostic indicator of cell proliferative disorders; antitumor agents; RNA interference; drug screening |
| 09/16/2008 | US7425611 Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425609 PRO4330 polypeptides |
| 09/16/2008 | US7425607 One or more lung tumor polypeptides and a carrier or immunostimulant; therapy and diagnosis of cancer, especially lung cancer |
| 09/16/2008 | US7425606 Identifying cryptic epitopes comprising amino acid sequences of tumor antigen for diagnosis and treatment of viral and cancer disorder; viricides; antitumor agents |
| 09/16/2008 | US7425605 PRO1486 polypeptides |
| 09/16/2008 | US7425540 Method for modification of NMDA receptors through inhibition of Src |
| 09/16/2008 | US7425536 Feline hepatocyte growth factor |
| 09/16/2008 | US7425535 Therapeutic pore-forming peptides |
| 09/16/2008 | US7425533 Modified hirudin proteins and T-cell epitopes in hirudin |
| 09/16/2008 | US7425531 Administering bone polypeptide-1 expressed by a nucleic acid for treating a bone disorder or osteoporosis of a patient |
| 09/16/2008 | US7425450 Regulatable growth of filamentous fungi |
| 09/16/2008 | US7425445 Using receptor tyrosine phosphatases as tools in identifying modulators for prevention and treatment of nervous system, cell proliferative and respiratory system disorders |
| 09/16/2008 | US7425444 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors |
| 09/16/2008 | US7425443 Treatment of diabetes with synthetic beta cells |
| 09/16/2008 | US7425438 Vector for anti-HPV vaccine and transformed microorganism by the vector |
| 09/16/2008 | US7425436 Covalent tethering of functional groups to proteins and substrates therefor |
| 09/16/2008 | US7425430 Probe for visualizing phosphorylation/dephosphorylation of protein and method of detecting and quantifying phosphorylation/dephosphorylation of protein |
| 09/16/2008 | US7425429 Method for the identification of tissue-specific regulatory sequences |
| 09/16/2008 | US7425428 Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby |
| 09/16/2008 | US7425420 Using g-protein coupled receptor to identify modulators for prevention and treatment of schizophrenia and related psychoses |
| 09/16/2008 | US7425339 for use in immunosuppressive therapy, in particular as inhibitors of cytotoxic T cell responses; for graft versus host disease/autoimmune disorders |
| 09/16/2008 | US7425338 Clostridial toxin derivatives and methods for treating pain |
| 09/16/2008 | US7425335 Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
| 09/16/2008 | US7425330 Methods of inhibiting TNFα activity in the blood of a patient |
| 09/16/2008 | US7425327 Choline binding proteins for anti-pneumococcal vaccines |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425324 Monocyte chemoattractant protein(MCP), mutants whose mucopolysaccharide binding site is eliminated by replacements, used to inhibit the migration and activation of leukocytes expressing their receptors; prevention of cancer, inflammatory, autoimmune and vascular diseases |
| 09/16/2008 | US7425317 Diagnosis, therapy of tumors, cancer |
| 09/16/2008 | CA2467801C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 09/16/2008 | CA2409748C Soluble ctla4 mutant molecules and uses thereof |
| 09/16/2008 | CA2313609C Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease |
| 09/16/2008 | CA2277757C Modified tumor necrosis factor |
| 09/16/2008 | CA2252799C Antiviral ricin-like proteins |
| 09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
| 09/16/2008 | CA2132091C Antibodies to alphavbeta3 integrin |
| 09/16/2008 | CA2123211C A method for assaying and treating alzheimer's disease |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/16/2008 | CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/15/2008 | CA2624573A1 Method of obtaining vegetable proteins and/or peptides, proteins produced according to said method and/or peptides and use thereof |
| 09/12/2008 | WO2008109833A2 Polynucleotides and polypeptides identified by iviat screening and methods of use |
| 09/12/2008 | WO2008109653A2 Peptides specific for human blood outgrowth endothelial cells |
| 09/12/2008 | WO2008109596A2 Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators |
| 09/12/2008 | WO2008109560A2 Amelioration of cellular stress response |
| 09/12/2008 | WO2008109410A1 Use of copper and glutamate in cell culture for production of polypeptides |
| 09/12/2008 | WO2008109342A1 Antagonists of the interaction of melanoma inhibitory activity (mia) and p66shc |
| 09/12/2008 | WO2008109167A2 Variant activin receptor polypeptides and uses thereof |
| 09/12/2008 | WO2008109079A2 High purity peptides |
| 09/12/2008 | WO2008109010A1 Treating stroke and other diseases without inhibiting n-type calcium channels |
| 09/12/2008 | WO2008108723A1 Diagnosis of collagen ix destruction |
| 09/12/2008 | WO2008108668A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |
| 09/12/2008 | WO2008108660A2 Fish disease detection |
| 09/12/2008 | WO2008108640A1 A gene mutated in fanconi anemia complementation group i |
| 09/12/2008 | WO2008108505A1 Novel nuclear translocation peptide |
| 09/12/2008 | WO2008108345A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein |
| 09/12/2008 | WO2008108285A1 Peptide |
| 09/12/2008 | WO2008108257A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 09/12/2008 | WO2008107722A2 Peptides, compositions and uses thereof |
| 09/12/2008 | WO2008107641A1 Liposome preparation |
| 09/12/2008 | WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | WO2008107416A1 Target of rapamycin modulators of and use thereof |
| 09/12/2008 | WO2008107400A1 Hcv polyepitope construct and uses thereof |
| 09/12/2008 | WO2008107370A1 Novel method and compositions |
| 09/12/2008 | WO2008107104A1 Isolated photoprotein mtclytindecay and the use thereof |
| 09/12/2008 | WO2008106896A1 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins |
| 09/12/2008 | WO2008106709A1 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS |
| 09/12/2008 | WO2008106707A1 Method of determining nt-probnp |
| 09/12/2008 | WO2008089831A3 G-protein coupled receptor 83 as a molecular switch for the induction of regulatory (immunosuppressive) t-cells |
| 09/12/2008 | WO2008089569A9 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 09/12/2008 | WO2008084478A3 Anti-bacterial peptides and methods of treating diseases using same |
| 09/12/2008 | WO2008080045A3 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 09/12/2008 | WO2008056376A3 A recombinant meso-active thermo-stable protein and the process of design and biosynthesis thereof |
| 09/12/2008 | WO2008048871A3 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/12/2008 | WO2008042421A3 Peptides derived from the c2 domain of epsilon pkc, and use thereof |
| 09/12/2008 | WO2008005533A3 Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance |
| 09/12/2008 | WO2007076162A3 Antimicrobial cathelicidin peptides |
| 09/12/2008 | WO2007059298B1 Chimeric immunoreceptor useful in treating human cancers |
| 09/12/2008 | WO2006038908A3 Ancestral and cot viral sequences, proteins and immunogenic compositions |
| 09/12/2008 | WO2005091856A8 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
| 09/12/2008 | CA2680196A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |
| 09/12/2008 | CA2680189A1 Modified enzyme and treatment method |
| 09/12/2008 | CA2680129A1 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | CA2679941A1 Use of copper and glutamate in cell culture for production of polypeptides |
| 09/12/2008 | CA2679926A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein |